Literature DB >> 25503701

Understanding the cytotoxicity or cytoprotective effects of biological and synthetic quinone derivatives by redox mechanism.

Rosivaldo S Borges1, Agnaldo S Carneiro, Tainá G Barros, Carlos A L Barros, Antonio M J Chaves Neto, Albérico B F da Silva.   

Abstract

Quinones represent an important class of biological compounds, but are also involved with toxicological intermediates and among their hazardous effects include cytotoxicity, immunotoxicity, and carcinogenesis. The structure-toxicity relationship for quinone derivatives has been used to cytotoxicity or cytoprotective effects by redox mechanism is determined using quantum chemical calculations through the density functional theory (DFT). According to our DFT study, the electron acceptance is related with LUMO, electron affinity, and stabilization energy values. The highest spin density distribution in the heteroatoms is more favored for the more cytotoxic compounds. The electrophilic capacities of these compounds have been related with LUMO values. The cytotoxic properties of quinones are related to the stabilization energy after electron accepting by redox mechanism. Electron affinity is the most relevant parameter related to toxicity mechanism. Regioisomers has different electrophilic capacity. The electrophilicity increases on molecules containing electron-withdrawing groups (EWG) and reduces on molecules containing electron-donating groups (EDG). These results explain the toxic difference between natural and synthetic quinone derivatives and can be used in the design and study of new drugs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25503701     DOI: 10.1007/s00894-014-2541-9

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  27 in total

Review 1.  Quinone chemistry and toxicity.

Authors:  T J Monks; R P Hanzlik; G M Cohen; D Ross; D G Graham
Journal:  Toxicol Appl Pharmacol       Date:  1992-01       Impact factor: 4.219

2.  A theoretical antioxidant pharmacophore for resveratrol.

Authors:  Auriekson N Queiroz; Bruno A Q Gomes; Waldir M Moraes; Rosivaldo S Borges
Journal:  Eur J Med Chem       Date:  2008-09-30       Impact factor: 6.514

3.  Role of metabolism and oxidation-reduction cycling in the cytotoxicity of antitumor quinoneimines and quinonediimines.

Authors:  G Powis; E M Hodnett; K S Santone; K L See; D C Melder
Journal:  Cancer Res       Date:  1987-05-01       Impact factor: 12.701

Review 4.  Metabolism and reactions of quinoid anticancer agents.

Authors:  G Powis
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

5.  Contribution of reductase activity to quinone toxicity in three kinds of hepatic cells.

Authors:  Yasuhiro Ishihara; Kaori Tsuji; Satomi Ishii; Kyoko Kashiwagi; Norio Shimamoto
Journal:  Biol Pharm Bull       Date:  2012       Impact factor: 2.233

6.  Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes.

Authors:  J E Laine; S Auriola; M Pasanen; R O Juvonen
Journal:  Xenobiotica       Date:  2009-01       Impact factor: 1.908

Review 7.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

Review 8.  The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers.

Authors:  Terrence J Monks; Douglas C Jones
Journal:  Curr Drug Metab       Date:  2002-08       Impact factor: 3.731

Review 9.  Acetaminophen-induced hepatotoxicity.

Authors:  Laura P James; Philip R Mayeux; Jack A Hinson
Journal:  Drug Metab Dispos       Date:  2003-12       Impact factor: 3.922

10.  Protein electrophile-binding motifs: lysine-rich proteins are preferential targets of quinones.

Authors:  Matthew T Labenski; Ashley A Fisher; Herng-Hsiang Lo; Terrence J Monks; Serrine S Lau
Journal:  Drug Metab Dispos       Date:  2009-02-27       Impact factor: 3.922

View more
  2 in total

Review 1.  The SARS-CoV-2 main protease (Mpro): Structure, function, and emerging therapies for COVID-19.

Authors:  Qing Hu; Yuan Xiong; Guang-Hao Zhu; Ya-Ni Zhang; Yi-Wen Zhang; Ping Huang; Guang-Bo Ge
Journal:  MedComm (2020)       Date:  2022-07-14

2.  Flavoenzyme-mediated reduction reactions and antitumor activity of nitrogen-containing tetracyclic ortho-quinone compounds and their nitrated derivatives.

Authors:  Milda Peciukaityte-Alksne; Jonas Šarlauskas; Lina Miseviciene; Audrone Maroziene; Narimantas Cenas; Kastis Krikštopaitis; Zita Staniulyte; Žilvinas Anusevicius
Journal:  EXCLI J       Date:  2017-05-11       Impact factor: 4.068

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.